Metaphedrine
![]() | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H17N |
| Molar mass | 163.264 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3-Methylmethamphetamine (3-MMA) or Metaphedrine is an amphetamine derivative which has been sold as a designer drug, first being reported in Sweden in 2021.[1]
See also
- 3-Chloromethamphetamine
- 3-Methoxymethamphetamine
- 3-Methylamphetamine
- 3-Methylmethcathinone
- 3-Me-PVP
- 4-Methylmethamphetamine
- Fenfluramine
- 3,4-Dimethylamphetamine
References
- ^ European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/882318 (inactive 12 July 2025). ISBN 978-92-9497-737-3.
{{cite book}}: CS1 maint: DOI inactive as of July 2025 (link)
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.
